Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Specker

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
RMD Open|October 21, 2021
TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMDAnne Constanze Regierer, Rebecca Hasseli, Martin Schäfer, et al.
Zeitschrift Fur Rheumatologie|August 7, 2020
[Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020]Hendrik Schulze-Koops, Christof Iking-Konert, Jan Leipe, et al.
Vaccines|February 26, 2026
Impact of the 2023/24 Influenza Vaccination on Patients with Inflammatory Rheumatic Disease in Germany: Insights from a Nationwide, Longitudinal, Self-Reported StudyKarolina Gente, Benedikt Ditz, Eike Bormann, et al.
Pharmacoepidemiology and Drug Safety|August 14, 2024
Rhekiss-The German Register for Child Wish and Pregnancies in Inflammatory Rheumatic DiseasesAnja Strangfeld, Yvette Meissner, Anja Weiß, et al.
Zeitschrift Fur Rheumatologie|December 12, 2024
[Criteria for the authorization of training in medical specialist competence in internal medicine and rheumatology-A position paper of the German Society for Rheumatology and Clinical Immunology]Alexander Pfeil, Martin Fleck, Martin Aringer, et al.
Zeitschrift Fur Rheumatologie|February 27, 2025
Criteria for the authorisation of specialty training for competence in internal medicine and rheumatology-a position paper of the German Society for Rheumatology and Clinical ImmunologyAlexander Pfeil, Martin Fleck, Martin Aringer, et al.
Zeitschrift Fur Rheumatologie|March 19, 2026
[Proposal of the rheumatology societies in the D-A-CH region for a uniform German nomenclature for Sjögren's disease]Diana Ernst, , Thomas Dörner, et al.
The Journal of Rheumatology|September 18, 2012
Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID)Petra Roll, Eva Ostermeier, Marion Haubitz, et al.
RMD Open|April 17, 2023
Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseasesRebecca Hasseli, Jutta G Richter, Bimba Franziska Hoyer, et al.
Rheumatology International|August 15, 2013
German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugsKatinka Albrecht, Klaus Krüger, Jürgen Wollenhaupt, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
RMD Open|October 21, 2021
TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMDAnne Constanze Regierer, Rebecca Hasseli, Martin Schäfer, et al.
Zeitschrift Fur Rheumatologie|August 7, 2020
[Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020]Hendrik Schulze-Koops, Christof Iking-Konert, Jan Leipe, et al.
Vaccines|February 26, 2026
Impact of the 2023/24 Influenza Vaccination on Patients with Inflammatory Rheumatic Disease in Germany: Insights from a Nationwide, Longitudinal, Self-Reported StudyKarolina Gente, Benedikt Ditz, Eike Bormann, et al.
Pharmacoepidemiology and Drug Safety|August 14, 2024
Rhekiss-The German Register for Child Wish and Pregnancies in Inflammatory Rheumatic DiseasesAnja Strangfeld, Yvette Meissner, Anja Weiß, et al.
Zeitschrift Fur Rheumatologie|December 12, 2024
[Criteria for the authorization of training in medical specialist competence in internal medicine and rheumatology-A position paper of the German Society for Rheumatology and Clinical Immunology]Alexander Pfeil, Martin Fleck, Martin Aringer, et al.
Zeitschrift Fur Rheumatologie|February 27, 2025
Criteria for the authorisation of specialty training for competence in internal medicine and rheumatology-a position paper of the German Society for Rheumatology and Clinical ImmunologyAlexander Pfeil, Martin Fleck, Martin Aringer, et al.
Zeitschrift Fur Rheumatologie|March 19, 2026
[Proposal of the rheumatology societies in the D-A-CH region for a uniform German nomenclature for Sjögren's disease]Diana Ernst, , Thomas Dörner, et al.
The Journal of Rheumatology|September 18, 2012
Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID)Petra Roll, Eva Ostermeier, Marion Haubitz, et al.
RMD Open|April 17, 2023
Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseasesRebecca Hasseli, Jutta G Richter, Bimba Franziska Hoyer, et al.
Rheumatology International|August 15, 2013
German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugsKatinka Albrecht, Klaus Krüger, Jürgen Wollenhaupt, et al.
Pageof 8